Immunomedics Inc.

(IMMU) Trade

By |

Profile

Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company's pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.

Contact Information

Website: www.immunomedics.com
Email: contact@immunomedics.com
Main Phone: +1 973 605-8200
Address: 300 The American Road
State: NJ
City / Town: Morris Plains
Country: USA
Postal Code: 07950

Issuer Information

Exchange: NSD
CEO: Michael F. Pehl
Employees: 185
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)
$ 18.73 $ -0.37 (-1.94%)
Last Price 18.73 Change $ -0.37 Change % -1.94 Tick N/A
Bid 18.12 Bid Size 500.00 Ask 19.85 Ask Size 900.00
Open 18.86 High 19.41 Low 18.60 Prev Close 19.10
Last Trade Volume 1.2 mi 52 Wk Hi 27.33 52 Wk Low 12.11
Market Cap 3.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 190,427,743.00 EPS (TTM) -1.27 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 36
Number of Buys 0 9
Number of Sells 0 27
Net Activity 0 6155861
Last 10 Buys Shares
Behzad Aghazadeh 1,000
Behzad Aghazadeh 1,000
Last 10 Sell Shares
David M. Goldenberg 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
Brian A. Markison 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 31 25 25 53
Low Target Price Estimate 20 20 20 22
Mean Target Price Estimate 24.33 22.33 22.33 34
Standard Deviation 5.86 2.52 2.52 13.29
Date of Most Recent Estimate 06/04/18 05/21/18 05/10/18 06/07/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1